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Abstract 
Background & Aims: Cholecystokinin (CCK) is a major gastrointestinal peptide 
hormone which is released postprandially from the small intestine and which exerts 
marked effects on gallbladder and gastrointestinal motility. The smaller isoforms 
CCK-8 and CCK-4 are rapidly taken up into hepatocytes, metabolized and excreted 
into bile. Our aim was to identify and characterize the hepatocellular CCK-8 uptake 
system. Methods: CCK-8 uptake was measured in X. laevis oocytes expressing the 
organic anion transporting polypeptides of rat (Oatp1, Oatp2, Oatp3 or Oatp4) and 
human liver (OATP-A, OATP-B, OATP-C or OATP8), and in primary cultured rat 
hepatocytes. Results: Rat Oatp4 and human OATP8 efficiently mediated CCK-8 
uptake in oocytes, with Km values of 14.9  2.9 M and 11.1  2.9 M, respectively. 
CCK-8 uptake by hepatocytes was also saturable, with a Km of 6.7 ± 2.1 M. The 
Km value in rat hepatocytes is consistent with Oatp4 mediated transport. 
Conclusion: CCK-8 is selectively transported by rat Oatp4 and human OATP8, both 
of which are exclusively expressed at the basolateral membrane of hepatocytes. 
These two transporters are the first and probably the predominant hepatic uptake 
systems for CCK-8 and may be critical for the rapid clearance of this hormone from 
the circulation. 
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Introduction 
Cholecystokinin (CCK) is a gastrointestinal peptide hormone with a wide range of 
biological activities. CCK is released postprandially from the intestinal wall and 
stimulates gallbladder contraction, the release of pancreatic enzymes and intestinal 
motility 1. Gastric emptying is delayed by CCK 2, whereas CCK-A receptor blockade 
accelerates gastric emptying 3. Among the various CCK isoforms the sulfated C-
terminal octapeptide (CCK-8) has repeatedly been reported to be biologically more 
active than CCK-39 or CCK-33 4-9, but other studies indicate that CCK-8 is not more 
potent than its larger analogues 10-12. Although CCK-8 shows no metabolic effect on 
hepatocytes it is efficiently taken up from portal blood into liver cells 13,14, where it is 
rapidly metabolized and finally excreted into bile 15. 
 
To date little is known about the molecular mechanism of hepatocellular CCK-8 
uptake. The existence of an efficient, highly specific and saturable transport system 
has been postulated and it has been shown that hepatic CCK-8 uptake is sodium-
independent and can be inhibited by DIDS, the organic anion bromosulphophthalein 
(BSP) and the bile salt taurocholate 14,16. These transport characteristics are typical 
for the organic anion transporting polypeptides (Oatps in rodents and OATPs in 
man), a family of plasma membrane carriers which are classified as SLC21A within 
the gene superfamily of solute carriers (Human Gene Nomenclature Committee 
Database). Oatps/OATPs are multispecific transporters that mediate the hepatic 
uptake of numerous amphipathic albumin bound compounds including bile salts, 
organic anions (e.g. BSP), conjugated steroids, eicosanoids, cardiac glycosides (e.g. 
ouabain and digoxin) and thyroid hormones. Interestingly, the Oatps/OATPs have 
also been shown to transport certain oligopeptides and peptidomimetic drugs, 
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including the thrombin inhibitor CRC 220 17,18, the opioid peptides [D-
penicillamine2,5]enkephalin (DPDPE) and deltorphin II, and the cyclic endothelin 
antagonist BQ-123 19-21. 
 
Recently, a new liver specific Oatp/OATP subfamily has been identified that is 
expressed exclusively at the basolateral membrane of hepatocytes. The human 
OATP-C (SLC21A6) is also termed “liver-specific transporter 1” (LST-1) or OATP2 22-
24 and is 64% identical with the rat homologue Oatp4 (Slc21a6) 25. Whereas Oatp4 is 
the only member of this subfamily identified in rat liver, human hepatocytes – in 
addition to OATP-C –  also express OATP8 (SLC21A8), which is 80% and 66% 
identical with human OATP-C and rat Oatp4, respectively 26. We have recently 
shown that OATP8 appears to be particularly efficient in the transport of certain 
peptides 21. 
 
In this study we show that hepatocellular CCK-8 uptake is indeed an Oatp/OATP 
mediated process. However, CCK-8 is selectively transported by Oatp4 in rat liver 
and OATP8 in human liver, indicating that these two transporters may be critical for 
CCK-8 clearance from the portal and systemic circulation. 
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Materials and Methods 
 
Materials. Radiolabeled [3H]CCK-8 (69 - 74 Ci/mmol) was obtained from Amersham 
Pharmacia Biotech (Buckinghamshire, UK). Collagenase type 2 CLS was from 
Worthington Biochemical Corp. (Freehold, NJ). All other chemicals were of the 
highest degree of purity available and were readily available from commercial 
sources. 
 
Uptake studies in Xenopus laevis oocytes. Capped Oatp/OATP cRNA was 
synthesized in vitro using the mMESSAGE mMACHINETM T7 kit (Ambion, Austin, 
TX) as described 21. X. laevis oocytes were prepared as described 27 and cultured 
overnight at 18°C. Healthy oocytes were microinjected either with 5 ng of the 
respective cRNA in a volume of 50 nl or with 50 nl of water and were subsequently 
cultured for 3 days in modified Barth’s solution at pH 7.6 28. All uptake studies were 
performed in a sodium-free medium containing 100 mM choline chloride, 2 mM KCl, 
1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES adjusted to pH 7.5 with Tris. Oocytes 
were prewashed in uptake medium and then incubated at 25°C in 100 l of uptake 
medium containing radiolabeled CCK-8 at the indicated concentrations. Water 
injected oocytes were used as controls for nonspecific uptake and binding of the 
substrate. Uptake was stopped by the addition of 6 ml ice-cold uptake medium and 
oocytes were washed in 2 x 6 ml of ice-cold uptake medium. Individual oocytes were 
lysed in 0.25 ml of 10% (w/v) SDS and 4 ml scintillation fluid (Ultima Gold; Canberra 
Packard, Zurich, Switzerland), and the oocyte associated radioactivity was 
determined in a Tri-Carb 2200 CA liquid scintillation analyzer (Canberra Packard). 
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Isolation of rat hepatocytes. Male Sprague-Dawley rats (200 - 250 g body weight) 
were anesthetized with sodium pentobarbital (Nembutal, Abbot, North Chicago, IL, 
50mg/kg body weight, intraperitoneally). Hepatocytes were isolated according to a 
slightly modified 2-step collagenase perfusion method as previously described 29. 
Cell viability was assessed by trypan blue exclusion and was more than 80 %. 2.4 x 
106 cells were seeded into 60 mm petridishes in Williams medium E supplemented 
with 2 mmol/l glutamine 100 U/ml penicillin, 100 µg/ml streptomycin, 250 nU/ml 
insulin, 1 µmol/l dexamethasone, and 10 % (v/v) fetal calf serum. Hepatocytes were 
allowed to attach for 3-4 hours at 37°C in a humidified atmosphere containing 5 % 
CO2. 
 
Uptake studies in hepatocytes. Immediately prior to uptake, the cell monolayer was 
washed 3 times with 3 ml of prewarmed (37°C) or ice-cold (4°C) uptake buffer 
consisting of 116 mmol/l NaCl, 5.3 mmol/l KCl, 1.1 mmol/l KH2PO4, 0.8 mmol/l 
MgSO4, 1.8 mmol/l CaCl2, 11 mmol/l D-glucose, and 20 mmol/l HEPES, pH 7.4. 
Uptake was started by the addition of 2 ml of uptake buffer (37° or 4°C) containing 
[3H]CCK-8 at the indicated concentrations. Uptakes were stopped by aspiration of the 
uptake buffer and four rapid washes with 3 ml of ice-cold substrate-free uptake 
buffer. Cells were lysed in 2 ml of 1 % (v/v) Triton X-100. 1 ml of the lysate was 
mixed with 5 ml of scintillation fluid (Ultima Gold; Canberra Packard, Zurich, 
Switzerland), and cell associated radioactivity was determined in a Tri-Carb 2200 CA 
liquid scintillation analyzer (Canberra Packard). Protein content of the lysates was 
measured with the bicinchoninic acid method (Pierce, Pockford, IL) using bovine 
serum albumin in 0.5 % (v/v) Triton X-100 as standard. 
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Statistical analysis. Uptake results are given as the mean  one standard deviation 
(SD). Differences in uptake between cRNA and water injected oocytes were tested 
for statistical significance using the unpaired Student t test. Statistical significance 
was assumed at p < 0.05. Kinetic parameters of uptake were calculated according to 
the Michaelis-Menten equation =Vmax·[S]/(Km+[S]). 
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Results 
 
We initially tested transport of [3H]CCK-8 by the known Oatps of rat liver. Three days 
after injection of cRNA into X. laevis oocytes, the liver specific Oatp4 (Slc21a6) 
efficiently mediated CCK-8 transport (25 fold stimulation of uptake as compared to 
water injected oocytes), whereas oocytes expressing either Oatp1 (Slc21a1), Oatp2 
(Slc21a5) or Oatp3 (Slc21a7) did not show any measurable uptake (Fig. 1A). We 
next tested the four OATPs expressed in human liver for their ability to transport 
CCK-8. Interestingly, only OATP8 (SLC21A8) efficiently transported CCK-8 (8 fold 
stimulation of uptake compared to water injected oocytes), whereas OATP-A 
(SLC21A3), OATP-B (SLC21A9) and OATP-C (SLC21A6) did not (Fig. 1B). CCK-8 
was thus shown to be transported selectively by Oatp4 of rat liver and OATP8 of 
human liver. 
 
We next analyzed the kinetic characteristics of Oatp4 and OATP8 mediated CCK-8 
transport. To determine the initial linear phase of CCK-8 uptake, time course 
experiments were performed using one low (0.5 mol/l) and one high (100 mol/l) 
concentration. At both substrate concentrations, uptake in Oatp4 and OATP8 
expressing oocytes increased linearly over at least 40 minutes, whereas nonspecific 
uptake and/or binding to water injected control oocytes did not increase with time 
(Figs. 2A and 2B). We therefore performed kinetic studies over a period of 20 
minutes using CCK-8 concentrations in the range of 0.5 to 100 M. Oatp4 mediated 
initial uptake rates were saturable with an apparent Km value of 14.9  1.5 M and a 
Vmax of 88.7  2.6 fmol/oocyte·min (Fig. 3A). OATP8-mediated CCK-8 uptake was 
also saturable, with an apparent Km value of 11.1  2.9 M and a Vmax of 55.1  
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4.0 fmol/oocyte·min (Fig. 3B). These results indicated highly comparable kinetic 
features for CCK-8 transport by the rat and human transporters. 
 
To correlate the kinetic features of Oatp4/OATP8 mediated CCK-8 uptake in oocytes 
with uptake in liver, CCK-8 uptake by primary cultured rat hepatocytes was 
measured. The specific protein-mediated portion of uptake was determined by 
subtracting uptake values at 4°C from those measured at 37°C. Initial uptake at 
concentrations of up to 30 M was linear over at least 1 minute (data not shown). 
Kinetic measurements using concentrations between 1-30 M showed saturability of 
CCK-8 uptake, with an apparent Km value of 6.7  2.1 M and a Vmax of 27.7  2.7 
fmol/mg x 20 seconds (Fig. 4). These data indicate that the affinity of Oatp4 for CCK-
8 is identical with that of the CCK-8 uptake system in rat hepatocytes. 
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Discussion 
 
Over the past two decades increasing evidence has suggested carrier-mediated 
hepatic uptake of the gastrointestinal peptide hormone CCK-8, including (i) a 
concentration gradient for this hormone between the portal and the systemic venous 
circulation 30, (ii) a reduced biological activity of CCK-8 after intraportal administration 
as compared to systemic administration 31, (iii) elevated CCK-8 plasma levels in 
patients with liver cirrhosis 32, (iv) rapid appearance of radiolabeled CCK-8 in the liver 
after intravenous injection, as shown by whole body autoradiography 33, and (v) 
uptake studies with radiolabeled CCK peptides in the isolated perfused rat liver and 
in primary cultured rat hepatocytes 14-16. 
 
In the present study, we show that CCK-8 is efficiently transported by Oatp4 of rat 
liver and OATP8 of human liver, whereas all other hepatic Oatps/OATPs did not 
transport this peptide. These findings are of particular interest for two reasons. First, 
they confirm previous functional studies, which had identified an Oatp-like transport 
system for CCK-8 in hepatocytes 14-16. Second, they identify CCK-8 as a specific 
physiological substrate of rat Oatp4 and human OATP8. It is noteworthy that OATP8 
but not OATP-C transports CCK-8, considering that these two carriers share an 80 % 
amino acid identity and exhibit closely overlapping substrate specificities including 
certain peptides 21. The results further confirm the notion that OATP8 is an uptake 
system for oligopeptides, whereas OATP-C is the more efficient transporter for 
organic anions including bilirubin 34. 
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The results of this study suggest that Oatp4 is the predominant CCK-8 transport 
system of rat hepatocytes. This conclusion is based on the following observations. 
First, Oatp4 transports CCK-8 in the absence of sodium and hepatocellular uptake of 
CCK-8 was shown to be sodium-independent 14. Second, kinetic studies of Oatp4 
mediated CCK-8 transport yielded an apparent Km value of 14.9  1.5 M. This 
would seem to be a low affinity if one considers that plasma CCK-8 concentrations 
are in the picomolar range. However, the data are in perfect agreement with the Km 
value of 6.7  2.1 M that was determined for CCK-8 uptake in primary cultured rat 
hepatocytes. The hepatocellular affinity for small CCK peptides such as CCK-4 also 
appears to be in the same range, since CCK-4 has been shown to inhibit 
hepatocellular CCK-8 uptake with an apparent Ki value of 63 M 14. Third, CCK-8 
uptake by rat hepatocytes has been shown to be competitively inhibited by the 
organic anion BSP and the bile salt taurocholate with apparent Ki values of 6.2 M 
and 17 M, respectively 14. This is in agreement with our recent findings that Oatp4 
mediates uptake of BSP and taurocholate with apparent Km values of 1.1 M and 
27 M, respectively 25. We therefore conclude that Oatp4 is the low affinity / high 
capacity CCK-8 uptake system of rat hepatocytes postulated by Gores and 
coworkers 14,16. 
 
In summary, we have shown that the hepatocellular uptake system for CCK-8 is 
Oatp4 in rats and most likely OATP8 in man. The selective transport of CCK-8 by rat 
Oatp4 and human OATP8 but not by other Oatps/OATPs suggests that intact 
function of Oatp4 and OATP8 may be critical for CCK-8 clearance from the 
circulation following its postprandial release from the intestine. 
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Figure legends 
 
Fig. 1:  Comparison of CCK-8 uptake by X. laevis oocytes expressing either (A) rat 
Oatps or (B) human OATPs. Oocytes were injected with 5 ng cRNA coding for the 
respective Oatp/OATP or with 50 nl water. After 3 days in culture, initial uptake of 
0.2 mol/l [3H]CCK-8 was measured over 30 minutes as described in “Materials and 
Methods”. Bars represent the mean  SD of 8-12 separate oocyte measurements. 
*statistically significant uptake by Oatp/OATP cRNA injected oocytes compared to 
water injected control oocytes. 
 
Fig. 2:  Time course of CCK-8 uptake by oocytes injected with Oatp4 cRNA (o), 
OATP8 cRNA (●) or water (▲). Uptake was measured at (A) 0.5 mol/l and (B) 100 
mol/l. Individual data points show mean  SD of 8-12 separate oocyte 
measurements. 
 
Fig. 3:  Kinetics of CCK-8 uptake in (A) Oatp4 and (B) OATP8 cRNA injected 
X. laevis oocytes. Oocytes were injected with 5 ng cRNA or with 50 nl water. After 3 
days in culture, uptake of [3H]CCK-8 was measured over 20 minutes at the indicated 
concentrations. Uptake values represent mean  SD of 8-12 separate oocyte 
measurements. Oatp/OATP specific uptake (-----) was calculated by subtracting 
nonspecific uptake in water injected oocytes (o—o) from uptake in cRNA injected 
oocytes (●—●). Curves were fitted by non-linear regression analysis. 
 
Fig. 4:  Kinetics of CCK-8 uptake in primary cultured rat hepatocytes. Hepatocytes 
were cultured for 3 hours and uptake of [3H]CCK-8 was measured over 20 seconds 
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at the CCK-8 concentrations indicated. Uptake values represent net protein-mediated 
uptake calculated by subtracting nonspecific uptake at 4°C from uptake at 37°C. Data 
are shown as the mean value of triplicate uptake experiments and the curve was 
fitted by non-linear regression analysis. 
 




